Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 817-187-7 | CAS number: 1803088-15-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test item is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the abscence and presence of metabolic activation.
The test item is also not mutagenic in the HPRT assay in the presence and absence of metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016-09-16 to 2016-09-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Version / remarks:
- 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature; under light exclusion ; no direct sunlight - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- induced rat liver S9 mix
- Test concentrations with justification for top dose:
- 1st experiment and 2nd experiment:
0; 33; 100; 333; 1000; 2500; 5000 µg/plate
Top dose of 5 mg/plate was selected in agreement with the current guidelines. - Vehicle / solvent:
- - Vehicle/solvent used: DMSO
- Justification for choice of solvent/vehicle: DMSO has been demonstrated to be suitable for bacterial reverse mutation tests and historical control data are available. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- other: 4-nitro-o-phenylenediamine (NOPD) without S9, strain: TA 98; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) without S9, strains: TA 1535 and TA 1537; 2-aminoanthracene (2-AA) with S9 all strains and without S9, strains: TA1537
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) and preincubation
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 - 72 h
SELECTION AGENT: -his and -trp deficient medium
NUMBER OF REPLICATIONS: 3 plates per dose
DETERMINATION OF CYTOTOXICITY
- decrease in the number of revertants (factor <= 0.6)
- clearing or diminution of the background lawn - Evaluation criteria:
- The test substance was considered positive in this assay if the following criteria were met:
- A dose-related and reproducible increase in the number of revertant colonies, i.e. at least doubling (bacteria strains with high spontaneous mutation rate, like TA 98, TA 100 and E.coli WP2 uvrA) or tripling (bacteria strains with low spontaneous mutation rate, like TA 1535 and TA 1537) of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system.
A test substance was generally considered non-mutagenic in this test if:
- The number of revertants for all tester strains were within the range of the historical negative control data under all experimental conditions in at least two experiments carried out independently of each other. - Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: none
- Effects of osmolality: none
- Evaporation from medium: no
- Water solubility: DMSO was used as vehicle
- Precipitation: was found from 33 µg/plate onward with and without S9 mix
HISTORICAL CONTROL DATA
- Positive historical control data: please refer to "Any other information on results" table 4
- Negative (solvent/vehicle) historical control data: please refer to "Any other information on results" table 4
CYTOTOXICITY
A weak bacteriotoxic effect (slight decrease in the number of his+ or trp+ revertants) was occasionally observed in the standard plate test depending on the strain and test conditions from about 1000 μg/plate onward. In the preincubation assay weak bacteriotoxicity (slight decrease in the number of his+ revertants) was occasionally observed depending on the strain and test conditions from about 33 μg/plate onward. Please also refer to "Any other information on results" table 3. - Conclusions:
- Under the experimental conditions chosen here, it is concluded that the test article is not a mutagenic test substance in the bacterial reverse mutation test in the absence and the presence of metabolic activation.
- Executive summary:
The test substance was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains in a reverse mutation assay. Salmonella typhimurium TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA were used as tester strains with a dose range of 33 μg - 5000 μg/plate in both standard plate test and preincubation test with and without metabolic activation (liver S9 mix from induced rats). Precipitation of the test substance was found from about 333 μg/plate onward with and without S9 mix. A weak bacteriotoxic effect was observed depending on the strain and test conditions from about 33 μg/plate onward. A relevant increase in the number of his+ or trp+ revertants (factor ≥ 2: TA 100, TA 98 and E.coli WP2 uvrA or factor ≥ 3: TA 1535 and TA 1537) was not observed in the standard plate test or in the preincubation test without S9 mix or after the addition of a metabolizing system. Under the experimental conditions of this study, the test substance GSID 1212253 is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-02-15 to
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Version / remarks:
- 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- other: in vitro gene mutation test in CHO cells (HPRT locus assay)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: batch number GSID 1212253-1 OP3
- Expiration date of the lot/batch: 2017-12-31
- Purity test date: not reported (stated in analytical report 16L00238, BASF SE)
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature (under light exclusion)
- Stability under test conditions: stable
- Solubility and stability of the test substance in the solvent/vehicle: The test susbtance is soluble and stable in DMSO., the stability over a period of 4 hours was verified analytically.
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The homogeneity of the test substance was ensured by mixing before preparation of the test substance solutions. - Target gene:
- hypoxanthine-guanine phosphoribosyl transferase (HPRT) locus
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CELLS USED
- doubling time of about 12 - 16 hours
- Methods for maintenance in cell culture: Stocks of the CHO cell line (1 mL portions) are maintained at -196 °C in liquid nitrogen using 7 % (v/v) DMSO in culture medium as a cryoprotectant.
MEDIA USED
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 mix, phenobarbital (i.p.) and β-naphthoflavone (orally) - induced
- Test concentrations with justification for top dose:
- Test concentrations were chosen based on the results of a pretest for dose selecetion and taking into accout the current guidelines.
Test concentrations of the 1st experiment:
without and with S9 mix [µg/mL]: 3.13; 6.25; 12.5; 25; 50; 100
Test concentrations of the 2nd experiment:
without and with S9 mix [µg/mL]: 4.69; 9.38; 18.75; 37.50; 75; 100 - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Due to insolubility of the test substance in water, dimethyl sulfoxide (DMSO) was selected as appropriate vehicle, which has been demonstrated to be suitable in the CHO/HPRT assay and for which historical control data are available. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 h
- Expression time (cells in growth medium): 7-9 days
- Selection time: 6-7 days
- Fixation time (start of exposure up to fixation or harvest of cells): cells were fixed with methanol directly after the selection period.
SELECTION AGENT: 6-thioguanine
NUMBER OF REPLICATIONS: 2
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: At the end of the selection period, the medium was removed and the remaining colonies were fixed with methanol, stained with Giemsa and counted.
NUMBER OF CELLS EVALUATED: The number of all colonies in each flask was counted and recorded for determination of mutant frequency and cloning efficiency.
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- A test substance is considered to be clearly positive if all following criteria are met:
• A statistically significant increase in mutant frequencies is obtained.
• A dose-related increase in mutant frequencies is observed.
• The corrected mutation frequencies (MFcorr.) exceeds both the concurrent negative/vehicle control value and the range of our laboratory’s historical negative control data (95 % control limit)
Isolated increases of mutant frequencies above our historical negative control range or isolated statistically significant increases without a dose-response relationship may indicate a biological effect but are not regarded as sufficient evidence of mutagenicity.
A test substance is considered to be clearly negative if the following criteria are met:
• Neither a statistically significant nor dose-related increase in the corrected mutation frequencies is observed under any experimental condition.
• The corrected mutation frequencies in all treated test groups is close to the concurrent vehicle control value and within the range of our laboratory’s historical negative control data (95 % control limit) - Statistics:
- An appropriate statistical trend test (MS EXCEL function RGP) was performed to assess a possible dose-related increase of mutant frequencies. The dependent variable was the corrected mutant frequency and the independent variable was the concentration. The trend was judged as statistically significant whenever the one-sided p-value (probability value) was below 0.05 and the slope was greater than 0. In addition, a pair-wise comparison of each test group with the vehicle control group was carried out using one-sided Fisher's exact test with Bonferroni-Holm correction. The calculation was performed using R.
If the results of these tests were statistically significant compared with the respective vehicle control, labels (s p ≤ 0.05) are printed in the tables. However, both, biological and statistical significance are considered together. - Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: pH values were not influenced by test substance treatment.
- Effects of osmolality: Osmolality was not influenced by test substance treatment.
- Precipitation: Precipitation was observed macroscopically In the 1st Experiment in the absence and the presence of S9 mix at the end of treatment at 50 μg/mL and above, and in the 2nd Experiment in the absence of S9 mix at 37.50 μg/mL and above and in the presence of S9 mix at 18.75 μg/mL and above. - Conclusions:
- The test substance is not mutagenic in the HPRT locus assay using CHO cells with and without metabolic activation under the experimental conditions chosen.
Referenceopen allclose all
Table 1. Experiment 1 standard plate incorporation test
Dose (µg/plate) |
Mean number of revertant colonies of 3 replicates (± S.D.) for different strains of S. typhimurium and E. coli |
||||
|
TA 100 |
TA 98 |
TA 1535 |
TA 1537 |
WP2 uvrA |
|
|
||||
|
Results without S9 |
||||
DMSO |
103.0 ± 14.0 |
21.7 ± 4.2 |
8.3 ± 1.5 |
8.0 ± 1.0 |
19.7 ± 1.2 |
33 |
107.0 ± 7.0 |
28.3 ± 6.4 |
12.7 ± 2.1 |
6.0 ± 1.0 |
13.0 ± 4.4 |
100 |
107.3 ± 15.0 |
25.0 ± 9.5 |
9.0 ± 3.5 |
9.0 ± 2.0 |
13.3 ± 3.2 |
333 |
103.3 ± 6.0 |
28.0 ± 11.3 |
9.0 ± 2.6 |
7.0 ± 1.0 |
15.0 ± 1.0 |
1000 |
94.7 ± 8.6 |
24.0 ± 1.0 |
7.3 ± 2.3 |
3.3 ± 1.5 |
12.7 ±4.5 |
2500 |
82.7 ± 15.0 |
10.0 ± 4.0 |
6.0 ± 3.6 |
3.7 ± 2.1 |
15.7 ± 1.5 |
5000 |
85.0 ± 5.6 |
8.3 ± 2.5 |
7.7 ± 1.5 |
4.3 ± 2.5 |
17.7 ± 6.1 |
MNNG (5) |
4149.7 ± 147.0 |
- |
4984.7 ± 175.6 |
- |
- |
NOPD (10) |
- |
909.7 ± 30.1 |
- |
- |
- |
AAC (100) |
- |
- |
- |
1997.7 ± 133.0 |
- |
4-NQO (5) |
- |
- |
- |
- |
1130.3 ± 48.2 |
|
|
||||
|
Results with S9 |
||||
DMSO |
112.0 ± 16.0 |
25.7 ± 5.5 |
9.0 ± 1.7 |
9.7 ± 3.5 |
26.3 ± 8.5 |
33 |
101.7 ± 7.5 |
28.3 ± 9.1 |
7.7 ± 2.3 |
12.0 ± 4.0 |
23.0 ± 9.6 |
100 |
95.3 ± 4.7 |
29.3 ± 6.7 |
8.0 ± 3.6 |
11.0 ± 2.6 |
25.0 ± 4.6 |
333 |
92.0 ± 27.6 |
28.7 ± 1.5 |
10.3 ± 2.1 |
7.7 ± 4.0 |
29.7 ± 8.1 |
1000 |
78.7 ± 7.5 |
22.7 ± 4.5 |
8.7 ± 2.1 |
6.7 ± 2.1 |
25.0 ± 1.7 |
2500 |
68.3 ± 8.4 |
12.7 ± 2.1 |
5.3 ± 0.6 |
6.0 ± 2.6 |
17.0 ± 3.6 |
5000 |
109.0 ± 14.2 |
21.7 ± 7.2 |
8.3 ± 2.1 |
8.3 ± 4.2 |
18.7 ± 3.5 |
2- AA (2.5) |
1467.3 ± 116.7 |
1234.3 ± 41.5 |
149.3 ± 12.4 |
118.7 ± 3.8 |
93.3 ± 21.2 |
Table 2. Experiment 2 Pre-incubation test
Dose (µg/plate) |
Mean number of revertant colonies of 3 replicates (± S.D.) for different strains of S. typhimurium and E. coli |
||||
|
TA 100 |
TA 98 |
TA 1535 |
TA 1537 |
WP2 uvrA |
|
|
||||
|
Results without S9 |
||||
DMSO |
94.7 ± 6.1 |
20.3 ± 6.4 |
15.3 ± 3.8 |
9.7 ± 3.1 |
20.0 ± 7.5 |
33 |
84.0 ± 3.5 |
19.0 ± 4.4 |
7.7 ± 1.2 |
9.0 ± 2.0 |
14.3 ± 2.5 |
100 |
92.0 ± 3.6 |
15.0 ± 3.6 |
7.7 ± 2.9 |
7.7 ± 2.1 |
13.7 ± 3.1 |
333 |
90.7 ± 8.1 |
18.0 ± 2.6 |
10.3 ± 6.5 |
11.0 ± 3.0 |
14.0 ± 2.6 |
1000 |
84.7 ± 12.9 |
13.0 ± 5.3 |
8.7 ± 2.1 |
11.7 ± 4.0 |
15.0 ± 5.6 |
2500 |
90.3 ± 14.6 |
17.7 ± 1.2 |
7.0 ± 2.6 |
11.0 ±4.4 |
13.0 ± 6.1 |
5000 |
76.0 ±8.7 |
13.0 ± 4.0 |
8.7 ± 1.5 |
6.3 ± 2.5 |
13.3 ± 3.1 |
MNNG (5) |
2189.0 ± 191.8 |
- |
2491.7 ± 96.4 |
- |
- |
NOPD (10) |
- |
811.0 ±41.4 |
- |
- |
- |
AAC (100) |
- |
- |
- |
1201.7 ± 148.5 |
- |
4-NQO (5) |
- |
- |
- |
- |
322.0 ± 18.1 |
|
|
||||
|
Results with S9 |
||||
DMSO |
124.0 ±16.7 |
22.3 ± 3.6 |
12.0 ± 3.5 |
11.0 ± 5.3 |
22.0 ± 3.6 |
33 |
71.3 ± 1.2 |
16.7 ± 3.8 |
8.7 ± 1.2 |
6.7 ± 3.8 |
16.7± 3.8 |
100 |
76.0 ± 8.0 |
16.0 ± 1.0 |
9.0 ± 4.4 |
9.0 ± 1.7 |
16.0 ± 1.0 |
333 |
67.0 ± 2.6 |
17.0 ± 2.6 |
8.0 ±4.6 |
10.3 ± 3.1 |
17.0 ± 2.6 |
1000 |
73.3 ± 18.5 |
14.7 ± 4.2 |
9.0 ± 4.6 |
9.0 ± 0.0 |
14.7 ± 4.2 |
2500 |
73.3 ± 8.3 |
16.7 ± 3.1 |
8.3 ± 2.3 |
9.0 ± 1.0 |
16.7 ± 3.1 |
5000 |
82.0 ± 11.3 |
14.7 ± 4.6 |
4.3 ± 0.6 |
5.3 ± 1.5 |
14.7 ± 4.6 |
2- AA (2.5) |
1187.7 ± 57.6 |
111.7 ± 6.4 |
167.7 ± 10.7 |
156.7 ±17.6 |
111.7 ± 6.4 |
Table 3. Decreased revertant numbers (cytotoxicity) observed at following concentrations (µg/plate)
Experiment |
S9 |
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
E. coli |
1st - SPT |
Without |
- |
- |
1000 - 5000 |
2500 - 5000 |
- |
With |
2500 |
|||||
2nd - PIT |
Without |
1000 - 5000 |
- |
- |
5000 |
- |
With |
5000 |
33 - 2500 |
5000 |
- |
- |
Table 4. Historical control data
|
|
Bacterial strains |
|||||
Historical control data of DMSO control |
-S9 |
|
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
E. coli |
Average |
18 |
95 |
10 |
7 |
22 |
||
SD |
3.1 |
9.9 |
2.2 |
1.5 |
4.0 |
||
Minimum |
12 |
69 |
6 |
5 |
12 |
||
Maximum |
30 |
140 |
17 |
12 |
33 |
||
+S9 |
|
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
E. coli |
|
Average |
24 |
100 |
10 |
8 |
23 |
||
SD |
4.7 |
12.3 |
2.1 |
2.2 |
4.0 |
||
Minimum |
13 |
76 |
6 |
5 |
13 |
||
Maximum |
35 |
150 |
18 |
16 |
35 |
||
Historical control data of positive control |
-S9 |
|
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
E. coli |
Average |
486 |
3331 |
4063 |
975 |
884 |
||
SD |
183.3 |
1021.5 |
1308.8 |
339.9 |
442.4 |
||
Minimum |
271 |
1125 |
1174 |
253 |
133 |
||
Maximum |
431 |
5557 |
6612 |
1858 |
1552 |
||
+S9 (2-AA |
|
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
E. coli |
|
Average |
1427 |
1792 |
217 |
130 |
98 |
||
SD |
361.9 |
448.9 |
50.0 |
33.6 |
26.6 |
||
Minimum |
431 |
361 |
108 |
56 |
54 |
||
Maximum |
2427 |
2819 |
367 |
241 |
169 |
Summary of results
Table 1: Experiment 1, 4 hour exposure period
Test group [µg/mL] |
S9 mix |
Cloning efficiency 1 (survival) |
Cloning efficiency 2 (viability) |
Mutant Frequency (per 10^6 cells) |
|||
Abs [%] |
Rel [%]* |
Abs [%] |
Rel [%] |
uncorrected |
corrected** |
||
Vehicle control (DMSO |
- |
170.0 |
100 |
83.5 |
100 |
3.25 |
3.89 |
+ |
99.8 |
100 |
84.3 |
100 |
1.75 |
2.08 |
|
3.13 |
- |
119.3 |
114.0 |
94.5 |
113.2 |
5.75 |
6.08 |
+ |
106.5 |
115.6 |
86.0 |
102.1 |
1.75 |
2.03 |
|
6.25 |
- |
153.0 |
149.8 |
100.0 |
119.8 |
3.25 |
3.25 |
+ |
87.0 |
104.8 |
100.5 |
119.3 |
3.0 |
2.99 |
|
12.5 |
- |
111.0 |
114.7 |
91.0 |
109.0 |
3.0 |
3.30 |
+ |
96.3 |
107.6 |
102.3 |
121.4 |
1.75 |
1.71 |
|
25.0 |
- |
114.3 |
119.1 |
98.0 |
117.4 |
2.25 |
2.30 |
+ |
95.3 |
98.9 |
87.3 |
103.6 |
1.25 |
1.43 |
|
50.0 |
- |
111.5 |
104.3 |
99.3 |
118.9 |
3.0 |
3.02 |
+ |
79.8 |
98.6 |
87.3 |
103.6 |
1.0 |
1.15 |
|
100.0 |
- |
96.5 |
97.4 |
93.8 |
112.3 |
3.5 |
3.73 |
+ |
87.5 |
100.2 |
88.0 |
104.5 |
0.75 |
0.85 |
|
EMS 400.0 |
- |
95.0 |
75.1 |
66.8 |
79.9 |
74.00 |
110.86 |
DMBA 1.25 |
+ |
70.5 |
77.2 |
77.5 |
92.0 |
74.0 |
95.48 |
* with regard to cell loss while exposure period, relative survival (RS) is calculated based on CE of cells plated immediatedly after treatment adjusted by any loss of cells during treatment as compared with adjusted cloning efficiency in vehicle/negative controls.
**correction on the basis of the absolute cloning efficiency 2 at the end of the expression period
Table 2: Experiment 2, 4 hour exposure period
Test group [µg/mL] |
S9 mix |
Cloning efficiency 1 (survival) |
Cloning efficiency 2 (viability) |
Mutant Frequency (per 10^6 cells) |
|||
Abs [%] |
Rel [%]* |
Abs [%] |
Rel [%] |
uncorrected |
corrected** |
||
Vehicle control (DMSO |
- |
87.5 |
100.0 |
91.8 |
100.0 |
4.0 |
4.36 |
+ |
75.3 |
100.0 |
82.8 |
100.0 |
3.5 |
4.23 |
|
4.69 |
- |
87.3 |
97.9 |
85.0 |
92.6 |
3.75 |
4.41 |
+ |
76.8 |
123.2 |
75.8 |
91.5 |
1.25 |
1.65 |
|
9.38 |
- |
87.0 |
103.0 |
98.5 |
107.4 |
5.0 |
5.08 |
+ |
77.5 |
127.3 |
84.7 |
102.4 |
1.75 |
2.06 |
|
18.75 |
- |
78.3 |
93.4 |
82.0 |
89.4 |
2.75 |
3.35 |
+ |
72.8 |
118.2 |
106.0 |
128.1 |
2.25 |
2.12 |
|
37.5 |
- |
69.5 |
87.6 |
72.3 |
78.7 |
1.75 |
2.42 |
+ |
71.3 |
115.6 |
76.8 |
92.7 |
3.75 |
4.89 |
|
75.0 |
- |
72.0 |
82.5 |
96.8 |
105.4 |
2.75 |
2.84 |
+ |
67.5 |
116.1 |
75.3 |
90.9 |
1.75 |
2.33 |
|
100.0 |
- |
67.8 |
81.3 |
95.3 |
103.8 |
4.0 |
4.20 |
+ |
62.0 |
104.8 |
71.8 |
86.7 |
6.5 |
9.06 |
|
EMS 400.0 |
- |
66.8 |
74.5 |
81.5 |
88.8 |
120.25 |
147.55 |
DMBA 1.25 |
+ |
51.3 |
88.5 |
64.0 |
77.3 |
74.0 |
115.63 |
* with regard to cell loss while exposure period, relative survival (RS) is calculated based on CE of cells plated immediately after treatment adjusted by any loss of cells during treatment as compared with adjusted cloning efficiency in vehicle/negative controls.
**correction on the basis of the absolute cloning efficiency 2 at the end of the expression period
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Bacterial reverse mutation assay
The test substance was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay.
STRAINS: TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA
DOSE RANGE: 33 μg - 5000 μg/plate (SPT); 33 μg - 5000 μg/plate (PIT)
TEST CONDITIONS: Standard plate test (SPT) and preincubation test (PIT) both with and without metabolic activation (liver S9 mix from induced rats).
SOLUBILITY: Precipitation of the test substance was found from about 333 μg/plate onward with and without S9 mix.
TOXICITY: A weak bacteriotoxic effect was observed depending on the strain and test conditions from about 33 μg/plate onward.
MUTAGENICITY: A relevant increase in the number of his+ or trp+ revertants (factor≥2: TA 100, TA 98 and E.coli WP2 uvrA or factor ≥ 3: TA 1535 and TA 1537) was not observed in the standard plate test or in the preincubation test without S9 mix or after the addition of a metabolizing system.
CONCLUSION: Under the experimental conditions of this study, the test substance is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
HPRT assay
The substance was assessed for its potency to induce gene mutations at the hypoxanthine-guanine phosphoribosyl transferase (HPRT) locus in Chinese hamster ovary (CHO) cells in vitro. Two independent experiments were carried out, both with and without the addition of liver S9 mix from phenobarbital- andβ-naphthoflavone induced rats (exogenous metabolic activation).
According to an initial range-finding cytotoxicity test for the determination of the experimental doses the following concentrations were tested and evaluated for gene mutations:
1st Experiment
without S9 mix 0; 3.13; 6.25; 12.50; 25.00; 50.00; 100.00μg/mL
with S9 mix 0; 3.13; 6.25; 12.50; 25.00; 50.00; 100.00μg/mL
2nd Experiment
without S9 mix 0; 4.69; 9.38; 18.75; 37.50; 75.00; 100.00μg/mL
with S9 mix 0; 4.69; 9.38; 18.75; 37.50; 75.00; 100.00μg/mL
Following attachment of the cells for 20 - 24 hours, cells were treated with the test substance for 4 hours in the absence and presence of metabolic activation. Subsequently, cells were cultured for 6 - 8 days and then selected in 6-thioguanine-containing medium for another week. Finally, the colonies of each test group were fixed with methanol, stained with Giemsa and counted.
The vehicle controls gave mutant frequencies within the range expected for the CHO cell line. Both positive control substances, ethyl methanesulfonate (EMS) and 7,12-dimethylbenz[a]-anthracene (DMBA), led to the expected statistically significant increase in the frequencies of forward mutations.
In this study, dose selection was based on the solubility properties of the test substance. The highest applied concentrations in both main experiments showed clear test substance precipitates in culture medium macroscopically at the end of exposure period. In both experiments in the absence and the presence of metabolic activation no cytotoxicity was observed up to the highest concentrations tested for gene mutations.
Based on the results of the present study, the test substance did not cause any biologically relevant or statistically significant increase in the mutant frequencies either without S9 mix or after the addition of a metabolizing system in two experiments performed independently of each other.
Thus, under the experimental conditions of this study, the test substance is not mutagenic in the HPRT locus assay under in vitro conditions in CHO cells in the absence and the presence of metabolic activation.
Justification for classification or non-classification
Classification,
Labelling, and Packaging Regulation (EC) No 1272/2008
The
available experimental test data are reliable and suitable for
classification purposes under Regulation (EC) No 1272/2008. The test
item was found to be not mutagenic in a bacterial reverse mutation assay
and in a HPRT assay. As a result the substance is not considered to be
classified as genotoxic under Regulation (EC) No 1272/2008, as
amended for the tenth time in Regulation (EU) No 2017/776.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.